cGxP.wire https://validator.w3.org/feed/docs/rss2.html Roche Presents Phase III Trontinemab Data at AAIC Aureka Launches OpenDDE to Advance AI Drug Discovery Montefiore Einstein Expands CGM Use to Improve Diabetes Care AMO Pharma Aligns Global Trial Plan for AMO-02 in cDM1 AbbVie Wins EU Approval for TEPKINLY in Follicular Lymphoma Movmedix Enters U.S. Market with FDA-Cleared LARS® Technology IceCure Expands ProSense Cryoablation in Brazil After FDA Clearance Aurinia Initiates Phase 4 LUPKYNIS Combination Trial Anixa Biosciences Advances Ovarian Cancer CAR-T to Highest Dose Genmab Wins EU Approval for TEPKINLY Plus R2 Lupin Earns TIME Recognition for Global Sustainability Leadership PharmaEssentia Wins Canadian Approval for BESREMi in Rare Blood Cancer Nabsys Appoints Alka Chaubey to Advance Genome Mapping Matica Bio, VaxDome Partner on Next-Gen Antiviral Vaccines Catheter Precision Wins Two Patents for VIVO and Cardionomix DarioHealth Expands Digital Care Through Arizona Insurer Deal ReproNovo Doses First Patient in Phase 2 NORDIC Trial Natera Signatera Predicts Chemotherapy Benefit in CRC Patients Astex and Genentech Partner to Advance Breast Cancer Drugs Pharvaris Advances Oral HAE Therapy with FDA NDA Acceptance Can-Fite Completes Phase 3 Psoriasis Trial Enrollment Novartis to Acquire Myricx Bio for Next-Gen ADC Innovation Invivyd Receives FDA EUA Termination Notice for PEMGARDA Arima Genomics Partners Active Motif for Hi-C Research Opus Genetics Secures FDA Alignment for Phase 3 Trial CervoMed Presents Neflamapimod DLB Data at AAIC TG Therapeutics Launches Phase 2 BRIUMVI Trial AtaiBeckley Completes Patient Dosing in Phase 2b VLS-01 TRD Trial Alzheon Showcases Long-Term Alzheimer’s Data for Valiltramiprosate at AAIC 2026 Mesoblast Receives FDA BLA Filing Number for Rexlemestrocel-L Oxford-Harrington and Oxford Launch £5.25M Pediatric Oncology Program Can-Fite Reports Positive Phase 2a Namodenoson Safety Datar Santhera Reports Positive Phase 1 AGAMREE Data InnoCare Doses First Patient in ICP-B208 ADC Clinical Trial Ascletis Submits FDA INDs for Next-Generation Obesity Drugs IntelliGenome Wins INVIMA Approval for CRISPR-TB Test FDA Approves Casgevy for Young Children With Sickle Cell Disease NewAmsterdam Pharma to Present Obicetrapib Alzheimer’s Data Evaxion to Present EVX-V1 CMV Vaccine Preclinical Data CraniUS Therapeutics Wins NIH Award for NeuroPASS Platform Artelo Biosciences Reports Positive ART26.12 Pain Data Sana Biotechnology to Present UP421 Clinical Data at EASD 2026 Oryzon Raises €12M to Accelerate Clinical Development Polyrizon Advances NASARIX™ Toward First-in-Human Trial Allarity Therapeutics Secures U.S. Patent for DRP® Platform Xeltis Surpasses 50% Enrollment in aXess US Trial M&M International Acquires KC Tech to Expand MedTech Portfolio Nuvaira Develops First Targeted Therapy for COPD Phenotype FDA Approves Tregzi to Prevent Chronic GVHD in Blood Cancer Immunomic Therapeutics Doses First Patient in ITI-9001 Trial